Squamous Cell Carcinoma of the Lip: Clinical Presentation and Management Outcome

Abstract

Background: Squamous cell carcinoma (SCC) is the second most common amongst skin cancers, following the basal cell carcinoma. SCC of the lip carries relatively better prognosis if detected early and treated adequately. Public awareness about the significance of early presentation would help to improve the outcome of management. Objective: The current study was conducted to determine the clinical presentation of lip SCC and management outcome with surgery as the primary treatment modality. Methods: This descriptive study was carried out at the National Institute of Rehabilitation Medicine, Islamabad over a period of seven years. All patients who presented with lip SCCs during the study period were prospectively included in the study. Non-consenting patients were excluded. The lesions were excised with 1-2-cm palpable macroscopic safety margins. Results: Out of 37 patients, there were 28 (75.67%) males and 9 (24.32%) females. The ages ranged between 47-79 years with a mean of 59.91±9.17 years. Lower lip was the most commonly affected site (n=30; 81.08%). The duration of the lesions at first presentation varied from 6-13 months with a mean of 7.32±1.79 months. Majority (n=31; 83.78%), of the patients had early stage (stage I and II disease) whereas 6(16.21%) patients had stage III disease. The margin clearance rate after initial excision of the lesions was 91.89%. Karapandzic flap was employed as reconstructive tool among 15(40.54%) patients. The 5-year overall survival rate was 62.16%. Conclusion: Lip SCCs were found more frequently among males aged over 50 years. Lower lip was the commonest seat of lip SCCs. Surgical excision with recommended safety margins was associated with tumor free margins in 91.89% cases. Karapandzic flap was the most useful reconstructive tool. The 5-year overall survival rate was 62.16%.